Pay in 4 interest-free payments of $5.12 Learn more
Ships within 48 hours · Estimated delivery Sep 8 - Sep 13
The percentage total weight loss (%TWL) was 10.97% [95% CI, 13.41 to 8.53
Eli Lilly and Companys new blockbuster weight loss drug, Zepbound (tirzepatide), has taken off, with 25,000 new prescriptions per week and more than $175 million in sales in its first few weeks on the market, according to the drug manufacturer
My name is Scott Henderson, and I live just outside Winnipeg, Manitoba
Fragrance-free and non-comedogenic formula tested for low irritation
1 " Mounjaro is expected to be available in Tirzepatide is also under regulatory review for the treatment of type 2 diabetes in About the SURPASS clinical trial program The SURPASS phase 3 global clinical development program for tirzepatide began in late 2018 and included five global registration trials and two regional trials in 2-8 SURPASS-1 (NCT03954834) was a 40-week study comparing the efficacy and safety of Mounjaro 5 mg (N=121), 10 mg (N=121) and 15 mg (N=120) as monotherapy to placebo (N=113) in adults with type 2 diabetes inadequately controlled with diet and exercise alone
US$ 24.72
US$ 23.33
US$ 20.64
US$ 24.99
US$ 29.22
US$ 20.66
US$ 26.02
